Navigation Links
DaVita Extends Lease to Maintain Strong Business Presence in Tacoma
Date:5/29/2009

FORTUNE 500 Company Signs New Leases Keeping Nearly 900 Jobs in the City

TACOMA, Wash., May 29 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced it has completed negotiations to extend its lease on office space at 1423 Pacific Avenue as well as at the Columbia Bank Center. DaVita currently has nearly 900 teammates (employees) located in Tacoma.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

"Tacoma is a great location for many of DaVita's important support operations and the wonderful teammates that help make DaVita one of 'The Best Places to Work,' according to Modern Healthcare Magazine. We are very pleased to extend our presence here," said Jim Hilger, Vice President and Controller at DaVita. "The City of Tacoma and the Economic Development Board for Tacoma-Pierce County have gone out of their way to assist DaVita during our search for solutions to our local office space needs. We appreciate their strong support and look forward to continuing our relationship."

Further details and terms of the lease agreements are not being released.

DaVita(R) is a registered trademark of DaVita Inc. All trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. Recognized as the only FORTUNE 500 company on WorldBlu's annual list of "Most Democratic Work Places," DaVita manages more than 1,400 outpatient facilities and
'/>"/>

SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Pamela M. Arway Joins DaVita Board of Directors
2. DaVita Announces New Corporate Headquarters in Denver, Colorado
3. DaVita Wins Eight Hermes Creative Awards Recognizing Excellence in Communications and Marketing
4. DaVita Becomes the First FORTUNE 500 Healthcare Services Company to Join the EPA Green Power Partnership
5. DaVita Announces Completion of Government Investigation
6. DaVita Donates More Than $1 Million in Scholarship Funds for Teammates Families
7. DaVita 1st Quarter 2009 Results
8. DaVita Wins Silver in Web Health Awards
9. DaVita Honored as First and Only FORTUNE 500 Company to Make List of Democratic Workplaces Since Its Inception in 1999
10. DaVita Dietitian Receives 2009 National Kidney Foundation Award for Outstanding Contributions to Renal Health
11. DaVita Wins Recruiting Department of the Year Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... The Cardiovascular Research Foundation (CRF) has announced ... will be presented at next month,s Transcatheter Cardiovascular ... premier educational meeting specializing in interventional cardiovascular medicine, ... at the Walter E. Washington Convention Center in ... TCT often direct the course of patient therapies. ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 ... Market Outlook to 2020", provides key market ... market. The report provides value, in millions ... average prices (in US dollars) within market ... Ultrasonic Generators and Argon Plasma Coagulation Generators. ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 In today’s ... overall development of an individual. Hence, these methods need ... and employability skills can be inculcated. In this age ... boost to these conventional methods. Thus, learning management systems ... methodologies. , As of now, these are proving ...
(Date:8/1/2014)... Aug. 1, 2014 (HealthDay News) -- Women who serve ... alcohol than their civilian peers, a new study suggests. ... to consume alcohol. However, these researchers found that women ... men. This may be due to concerns about sexual ... use is tightly linked to sexual assault, both within ...
(Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- Roaming the ... preserved mummy became famous as the "Ice Man" no doubt ... of that may still not have shielded the Ice Man, ... A human,s genetic risk for atherosclerosis, or "hardening of the ... thousands of years ago, a new study finds. ...
Breaking Medicine News(10 mins):Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 2Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 3Health News:CRF announces late-breaking trials and first report investigations for TCT 2014 4Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 2Health News:United Kingdom Surgical Generators Market Size, Share, Analysis, Trends and Forecasts 2020 3Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:North America Learning Management System Market is Expected to Reach $5.13 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Women in Military Drink Less Than Civilians, Report Shows 2Health News:'Ice Man' Mummy May Have Been at Risk of Heart Disease 2
... Structural biologists at Cold Spring Harbor Laboratory (CSHL) have ... for an allosteric inhibitor in a subtype of the ... cells. The newly discovered binding site -- ... because it is a potential target for drugs that ...
... , THURSDAY, June 16 (HealthDay News) -- ... else is making many people with middle and low ... grown a lot in the U.S., especially since the ... University of Virginia, said in news release from the ...
... By Denise Mann HealthDay Reporter , WEDNESDAY, June ... some people stopped flying out of fear of catching the virus ... new study shows that the "danger zone" for flu transmission is ... had been thought that this hot zone was much larger, according ...
... WEDNESDAY, June 15 (HealthDay News) -- Men who struggle with ... new study suggests. The study, by researchers from ... found that impotence, or erectile dysfunction, was more common among ... frequent the symptoms of the sleep disorder the higher the ...
... HealthDay Reporter , TUESDAY, June 14 (HealthDay News) -- For ... simple as sleeping on their left side, New Zealand researchers ... sleep on their left side had twice the risk of ... increase in risk [from right-sided sleeping] is small for the ...
... used cutting-edge stem cell technology to correct a genetic ... on a promising path that may one day lead ... diseases such as macular degeneration and retinitis pigmentosa which ... in an advance online publication of the journal ...
Cached Medicine News:Health News:CSHL structural biologists reveal novel drug binding site in NMDA receptor subunit 2Health News:Study Finds Two-Seat 'Hot Zone' for Flu Spread on Planes 2Health News:Study Finds Two-Seat 'Hot Zone' for Flu Spread on Planes 3Health News:Study Finds Two-Seat 'Hot Zone' for Flu Spread on Planes 4Health News:Impotence Linked to Restless Legs Syndrome 2Health News:Could Sleeping on Left Side Help Prevent Stillbirth? 2Health News:Could Sleeping on Left Side Help Prevent Stillbirth? 3Health News:Researchers report progress using iPS cells to reverse blindness 2
(Date:7/31/2014)... -- STAAR Surgical Company (NASDAQ: STAA ) ... and delivery systems for the eye today reported revenue ... $20.0 million, a 10% increase over $18.2 million reported ... currency basis, revenues grew 11% during the second quarter ... The effect of foreign currency exchange reduced sales by ...
(Date:7/31/2014)... Xencor Inc. (NASDAQ: XNCR ... antibodies for the treatment of autoimmune diseases, asthma ... results for the second quarter ended June 30, 2014 ... "In the second quarter, we presented ... International Conference (ATS) demonstrating three novel mechanisms of ...
(Date:7/31/2014)... , July 31, 2014  Alexza Pharmaceuticals, Inc. ... update on its pipeline and new product development ... to initiate a Phase 2a study of AZ-002 ... for the management of patients with acute repetitive ... Staccato -based product candidates for development - AZ-008 ...
Breaking Medicine Technology:STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31Xencor Reports Second Quarter 2014 Financial Results 2Xencor Reports Second Quarter 2014 Financial Results 3Xencor Reports Second Quarter 2014 Financial Results 4Xencor Reports Second Quarter 2014 Financial Results 5Xencor Reports Second Quarter 2014 Financial Results 6
... Sept. 17 Pharmasset, Inc.,(Nasdaq: VRUS ) management ... held from September 22-25, 2008 at the Grand Hyatt ... Officer,will provide an overview of the company on Wednesday, ... To access a live webcast of Mr. Price,s ...
... CT Colonography Trial Raise Questions for,Patients, OAK ... CT Colonography Trial, published in the September 18 ... improvements in the technology,s,ability to diagnose intermediate- to ... testing is not as effective in diagnosing small ...
Cached Medicine Technology:Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th 2ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 2ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 3ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 4ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 5